Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (5747)	3/19/2002 10:59:02 AM
From: Jibacoa	Read Replies (2) of 52153

The coated stent market. It seems JNJ's sirulimus coated catheter remains on the lead. BSX's paclitaxel coated is #2 as GDT's actinomycin-D coated is out of the competition and its paclitaxel coated has legal problems with BSX.<g> biz.yahoo.com biz.yahoo.com biz.yahoo.com biz.yahoo.com No charts,<g>, but JNJ continues on a strong up-trend since its February L with its intra-day H of 65.47 on Friday. RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next